Articles tagged "Blood transfusion"

2020 American Transplant Congress
Operative vs. Non-Operative Management of Hemorrhage in the Postoperative Kidney Transplant Patient
R. Shaw¹, T. Reavis¹, V. Meruva², F. Montz³, E. Rogers⁴, A. Kumar¹, V. Bowers⁴, J. Buggs⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Lake Erie College of Osteopathic Medicine, Bradenton, FL, ³University of Tampa, Tampa, FL, ⁴Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Postoperative hemorrhage has been described at rates of 14 percent in kidney transplant (KT) literature. The preferred management of postoperative hemorrhage in this population…
2020 American Transplant Congress
Passenger Lymphocyte Syndrome Due to Anti-Rh(D) Reactivity after Kidney Transplantation: A Case Report
S. Nemr¹, S. Bani Hani¹, E. Klohe², C. Gresens³, S. Desmond¹, O. Ojogho¹
¹Kidney and Pancreas Transplant Program, Providence Sacred Heart Medical Center & Children's Hospital, Spokane, WA, ²HLA Laboratory, Inland Northwest Blood Center, Spokane, WA, ³Inland Northwest Blood Center, Spokane, WA
*Purpose: PLS can occur soon after solid organ transplantation when donor-derived antibodies against recipient red cell antigens are produced and lead to hemolysis. The anemia…
2019 American Transplant Congress
The Comparative Safety and Efficacy of Direct Acting Oral Anticoagulants Relative to Warfarin Following Liver Transplantation
A. Santeusanio, A. Weinberg, T. Schiano
Mount Sinai Hospital, New York, NY
*Purpose: This study describes the comparative safety and efficacy of direct acting oral anticoagulants (DOACs) relative to warfarin following liver transplantation, at a large academic…
2019 American Transplant Congress
Visceral Arterial Embolization – An Important Tool For Managing Blood Loss In Multivisceral Transplant Candidates With Portomesenteric Thrombosis
D. P. Borle, J. A. Shah, R. Kadiyala Venkata, D. Vikraman, B. Collins, S. Knechtle, A. Rege, A. Barbas, C. Kim, T. Smith, P. Sohocki, D. L. Sudan
Duke University Medical Center, Durham, NC
*Purpose: Organ explant in multivisceral transplant (MVT) candidates is technically demanding associated with high volume blood loss. Visceral arterial embolisation (VAE) may reduce bleeding, but…
2019 American Transplant Congress
Idarucizumab For The Reversal Of Dabigatran In Patients Undergoing Heart Transplantation
J. Van Keer¹, T. Vanassche¹, W. Droogne¹, S. Rex², F. Rega³, J. Van Cleemput¹, P. Verhamme¹, M. Naesens⁴
¹Cardiology, University Hospitals Leuven, Leuven, Belgium, ²Anesthesiology, University Hospitals Leuven, Leuven, Belgium, ³Cardiovascular Surgery, University Hospitals Leuven, Leuven, Belgium, ⁴Nephrology, University Hospitals Leuven, Leuven, Belgium
*Purpose: Atrial fibrillation is common among patients with advanced heart failure who are listed for transplantation. Idarucizumab is a monoclonal antibody fragment that was developed…
2019 American Transplant Congress
Efficacy of Long-Acting Octreotide in Left Ventricular Assist Device Patients with Recurrent Gastrointestinal Bleeding
T. Wilson¹, D. Baran², J. Herre², C. Cameron¹, W. Old³, G. Zeevi², C. Barreiro⁴, C. Kemp⁴, J. Philpott⁴, A. Ingemi⁵
¹Pharmacy Department, Sentara Norfolk General Hospital, Norfolk, VA, ²Advanced Heart Failure Department, Sentara Norfolk General Hospital, Norfolk, VA, ³Bayview Cardiovascular Associates, Norfolk, VA, ⁴Division of Cardiothoracic Surgery, Sentara Norfolk General Hospital, Norfolk, VA, ⁵Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA
*Purpose: Continuous flow ventricular assist device (VAD) patients have a high risk of recurrent gastrointestinal bleeding, often leading to readmission and morbidity. Intramuscular long-acting octreotide…
2019 American Transplant Congress
Perioperative Blood Transfusion and Risk for Post-Transplant Sensitization and Rejection
A. Chung¹, M. Kleman¹, T. Pesavento¹, M. Abdel-Rasoul², R. Daloul¹
¹Internal Medicine, Division of Nephrology, The Ohio State University, Columbus, OH, ²Center for Biostatistics and Bioinformatics, The Ohio State University, Columbus, OH
*Purpose: Pre-transplant blood transfusion is a well-established risk factor for sensitization to human leukocyte antigens (HLA). HLA sensitization is associated with increased wait-list time, risk…
2019 American Transplant Congress
Intraoperative Blood Loss and Transfusion during Pediatric Liver Transplantation: A Single Center Experience
J. A. Villarreal¹, D. Yoeli², J. Yoeli³, R. Ackah⁴, R. Sigireddi¹, M. Kueht¹, N. Galvan¹, R. Cotton¹, A. Rana¹, C. O’Mahony¹, J. Goss¹
¹Surgery, Baylor College of Medicine, Houston, TX, ²Surgery, University of Colorado School of Medicine, Denver, CO, ³Pediatrics, University of Colorado School of Medicine, Denver, CO, ⁴Surgery, The Ohio State University College of Medicine, Columbus, OH
*Purpose: The aim of this study is to identify risk factors for massive intraoperative blood loss and transfusion in pediatric liver transplant recipients and describe…
2019 American Transplant Congress
Long Term Impact of Intraoperative Autologous Blood Transfusion on HCC Recurrence in Liver Transplantation
G. Kelly¹, J. L. Pasko¹, E. Dewey², E. Maynard¹, S. L. Orloff¹, C. Enestvedt¹
¹Division of Abdominal Transplant, OHSU, Portland, OR, ²Department of General Surgery, OHSU, Portland, OR
*Purpose: The aim of this study was to determine whether intraoperative autologous transfusion in liver transplant patients with HCC affects the rate of recurrence.*Methods: We…
2019 American Transplant Congress
Optimizing Patient Blood Management in Simultaneous Kidney and Pancreas Transplantation
D. P. Al-Adra, J. Odorico, D. Kaufman, R. Redfield, J. P. Connor
University of Wisconsin, Madison, WI
*Purpose: To identify a post-operative hematocrit (Hct) target for patients recovering from simultaneous kidney and pancreas (SPK) transplant and pancreas transplant alone (PTA) that is…